Allan C Just, PhD
- ASSISTANT PROFESSOR | Environmental Medicine & Public Health
Research Topics:
Epigenetics, Molecular EpidemiologyAllan Just, PhD is an environmental epidemiologist and serves as an Assistant Professor in the Department of Environmental Medicine and Public Health. His research interests are in children’s environmental health, computational methods for epigenomics, environmental epigenomics, endocrine disrupting compounds, and air pollution modeling using satellite data. He uses large datasets, computational tools, and the methods of molecular epidemiology to investigate links between environmental exposures and children's health.
Dr. Just's R00 grant is based in the Mexico City cohort of the Programming Research in Obesity, Growth, Environment, and Social Stressors (PROGRESS) study as well as the Programming of Intergenerational Stress Mechanisms (PRISM) study. He is collaborating with the National Institute of Public Health, Mexico on a grant from the Mexican National Council of Science and Technology (CONACyT) that addresses air pollution and health using the Mexican National Health and Nutrition Examination Survey (ENSANUT). He is also in the coordinating groups for several epigenomic meta-analyses as part of the Prenatal and Childhood Epigenetics (PACE) consortium and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Dr. Just received his PhD in Environmental Health Sciences from Columbia University in 2012. Since 2012 he completed a postdoctoral fellowship in Environmental Epigenetics at the Harvard T.H. Chan School of Public Health, before joining the Icahn School of Medicine at Mount Sinai in September of 2015. Dr Just is a past recipient of an EPA STAR graduate fellowship for his dissertation work on phthalate mixtures and children’s respiratory health and was awarded a K99/R00 grant from the National Institute of Environmental Health Sciences entitled “Prenatal Exposure to Endocrine Disrupters, DNA Methylation, and Childhood Obesity” (R00ES023450).
-
2014
Prenatal Exposure to Endocrine Disrupters, DNA Methylation, and Childhood Obesity NIEHS
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Just did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.